期刊文献+

肾消康对糖尿病大鼠肾组织基因Cxcl12表达的影响 被引量:2

Effect of ShenXiaoKang on Diabetic Nephropathy Rats Renal Tissues Gene-Cxcl12 Expresstion
原文传递
导出
摘要 目的:比较糖尿病肾病大鼠和中药复方肾消康治疗组大鼠肾脏组织中基因表达的差异。方法:实验大鼠分为正常组、模型组、治疗组。从肾脏组织中抽提mRNA,由纯化的总RNA合成双链cDNA,并将其纯化,以生物素标记cRNA合成,纯化和质控体外转录(IVT)产物,片断化cRNA,然后进行杂交、洗脱、染色、芯片扫描并用软件进行统计分析,筛选出差异表达数据。不同肾脏组织样本用灰度扫描图和杂交信号强度散点图表示。结果:仅对筛选出差异表达基因谱中的Cxcl12进行报告。糖尿病肾病模型组肾脏组织基因Cxcl12表达上调,中药复方肾消康治疗组肾脏组织基因Cxcl12表达下调。结论:Cxcl12在糖尿病状态下肾脏也有表达,并且表达上调,而中药复方肾消康可使其下调,这也是中药复方对糖尿病性肾组织损伤具有保护作用的机制之一。 Objective: To study the difference of renal tissues gene - expression between diabetic nephropathy rats and rats therapied by herb prescription. Methods: Experimental rots were made of: normal.model and therapy. To abstract mRNA into from renal tissues firstly ; to make purification total RNA into suplex cDNA; to sublimate cDNA ; to compose cRNA which labeled with biotin;to sublimate and control transcript product in vitro;to fragment cRNA ;to hybridize and wash and stain and scan finally, cDNA probes were hybridized with gene chip and make a result through scan and software analysis. To select those data. Different renal tissues samples were labeled by two kinds of grey degree scan and scatter graph. Results:Get different expression Gene -Cxcll2. The expression of diabetic nephropathy gene -Cxcll2 is up,while the expression of rats renal gene - Cxc112 therapied by Shenxiaokang is down. Conclusion:The paper only report one gene - Cxcll2 of rats renal gene expression profiles, renal tissues gene - Cxcll2 is also expressed when suffering from diabetic and the number of expression is more than normal. While Shenxiaokang can make the number of this gene expression less significantly. This is one of protection mechanisms of diabetic renal tissues damage therapied by herb prescription.
出处 《中华中医药学刊》 CAS 2009年第11期2254-2256,共3页 Chinese Archives of Traditional Chinese Medicine
基金 黑龙江省杰出青年基金课题(2070222)
关键词 肾消康 糖尿病 肾组织损伤 Cxcll2 Shenxiaokang diabetes mellitus renal tissues damage Cxcll2
  • 相关文献

参考文献1

二级参考文献13

  • 1李荣芬,王银娜,李英.血管内皮生长因子基因多态性与糖尿病肾病的相关性研究[J].中华肾脏病杂志,2005,21(1):18-21. 被引量:4
  • 2Lee SJ, Lee SY,Jeon I-IS, et al. Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer. Cancer Ep idemiol Biomarkers Prey, 2005,14 : 571-575.
  • 3Morohashi K, Takada T, Omori K, et al. Vascular Endothelial Growth Factor Gene Polymorphisms in Japanese Patients With Sarcoidosis. J Chest, 2003,123 : 1520-1526.
  • 4Shahbazi M, Fryer AA, Pravica V, et al. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol, 2002 ; 13 : 260-264.
  • 5Cha DR, Kang YS, Han SY, et al. Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats. J Endoerinol, 2004,183 : 183-194.
  • 6Kanesaki Y, Suzuki D, Uehara G, etc al. Vascular endothelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic nephropathy. Am J Kidney Dis, 2005,45 : 288-294.
  • 7Cha DR, Kim NH, Yoon JW, et al. Role of vascular endothelial growth ~actor in diabetic nephropathy. Kidne Int, 2000, 58: S104 -S112.
  • 8Hohenstein B, Hausknecht B, Boehmer K. Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man. Kidney Int, 2006,69 : 1654-1661.
  • 9Chiarelli F, Spagnoli F, Basciani S, et al. Vascular endothelial growth factor(VEGF) in children, adolescents and young adults with type 1diabetes mellitus: relation to glycaemic control and microvascular complications. Diabet Meal,2000,17 : 650 -656.
  • 10Wasada T, kawabara R, Katsumori K, et al. Plasma concentration of irnmunoreactive vascular endothelial growth factor and its relation to smoking. Metabolism, 1998,47 : 27- 30.

共引文献10

同被引文献23

  • 1王海颖,陈以平.牛蒡子提取物减轻糖尿病大鼠肾脏病变的机理研究[J].中医药学刊,2004,22(7):1250-1252. 被引量:15
  • 2Modin A,Malmstr M R E,Meister B.Vascular neuropeptideY Y1-re-ceptors in the rat kidney:vasoconstrictor effects and expression of Y1-receptormRNANeuropeptides,1999.
  • 3Savill J.Apoptosis:a mechanism for regulation of the cell complementof inflamed glomeruliKidney International,1992.
  • 4Leehey DJ,Singh AK,Alavi N,et al.Role of angiotensinⅡin diabeticnephropathyKidney International,2000.
  • 5Shin LH,Dovgan PS,Nypaver TJ,et al.Role of neuropeptide Y in the development of two-kidney, one-clip renovascular hypertension in the ratJournal of Vascular Surgery,2000.
  • 6Zent R,Pozzi A.Angiogenisis in Diabetic NephropathySeminars in Nephrology,2007.
  • 7Giunti S,Barit D,Cooper ME.Diabetic nephropathy:frommechanisms to rational therapiesMinerva Medica,2006.
  • 8Pavenstadt H,Kriz W,Kretzler M.Cell biology of the glomeru-lar podocytePhysiological Reviews,2003.
  • 9Ferrario CM,Jessup J,Gallagher PE,et al.Effects of renin-an-giotensin system blockade on renal angiotensin-(1-7)formingenzymes and receptorsKidney International,2005.
  • 10SUGIM OTO H,SH IKATA K,H IRATA K,et al.Increased expression ofintercellular adhesion m olecule-1(ICAM-1)in diabetic rat glom eruli:glom erular hyperfiltration is a potential m echanism of ICAM-1upregulationDiabetes,1997.

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部